Quince Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
3.00
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-0.10
|
-0.13
|
-0.03
|
-27.20%
|
|
2024-06-30
|
0.00
|
-0.64
|
0.00
|
0.00%
|
|
2024-03-31
|
0.00
|
-0.22
|
0.00
|
0.00%
|
|
2023-12-31
|
-0.28
|
-0.22
|
0.06
|
21.43%
|
|
2023-09-30
|
0.00
|
-0.15
|
0.00
|
0.00%
|
|
2023-06-30
|
0.00
|
-0.14
|
-0.14
|
0.00%
|
|
2023-03-31
|
-0.31
|
-0.34
|
-0.03
|
-10.54%
|
|
2022-12-31
|
-0.29
|
-0.15
|
0.14
|
47.84%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-0.99
|
|
2023-12-31
|
-0.85
|
|
2022-12-31
|
-1.60
|
|
2021-12-31
|
-3.03
|
|
2020-12-31
|
-2.63
|
|
2019-12-31
|
-2.90
|